Dusk Group (ASX:DSK) isn’t smelling so good after its 1HY23 results

Nick Sundich Nick Sundich, February 24, 2023

Dusk Group (ASX:DSK) is the latest company that saw a sales growth amidst the pandemic to report a ‘return to normal’ in its 1HY23 result. This company provides home fragrance products including candles, diffusers and essential oils, both online and at its network of ~140 stores. 

 

 

No time to do stock research, but you still want to invest?

 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 
DSK has some good metrics, but sales and earnings are down

Turning to the figures that matter most, although DSK’s total sales grew 7.6%, this figure was only higher due to lockdowns that closed a number of stores in the prior corresponding period.

Like for like sales, which means total sales excluding stores closed because of COVID, fell by 10.4%. Online like for like sales fell by 37.8%, reflecting the return of consumers to brick and mortar stores. The company’s NPAT was $13.3, which was 9.5% lower and represents a 15.5% margin (down from 18.4%). 

There were some metrics that appeared positive, however. One was the continue growth in its reward program from 718,000 to 722,000. These members accounted for 59% of total sales and had a higher average transaction value compared to non-members. 

Most pleasingly for investors, DSK paid an interim dividend of 8c per share which was an 8.5% yield on an annualised yield. 

 

An uncertain outlook

DSK also reported that total sales for the first 7 weeks of 2HY23 were 3% lower compared to the prior corresponding period and it declined to give FY23 earnings guidance.

The company is looking for a new CEO, to replace Peter King, and it will open 6 further stores in the coming months. 

 

Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
 
With price targets, buy ranges, stop loss levels and Sell alerts too.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Trump vs. Jerome Powell

Trump vs. Jerome Powell: What Happens to the Market If Powell Is Fired?

The relationship between President Donald Trump and Federal Reserve Chair Jerome Powell has often been tumultuous, particularly around decisions regarding…

Telix Pharmaceuticals on the Nasdaq

Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!

What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…

anti woke ETFs

Anti Woke ETFs: Do they practice what they preach and have they outperformed since Trump’s return to power?

Have you ever heard of so-called ‘Anti Woke ETFs’? If you’re sick of companies that are big on ESG, this…